Cort-dome, Plenadren(hydrocortisone)
/ Hydrocortisone, / Hydrocortisone / Neomycin / Polymyxin B, Acetic Acid, Achromycin, Ala-cort, Ala-scalp, Alkindi, Alphaderm, Anusol, Calmurid, Casporyn, Cipro, Colocort, Coly-mycin, Cor-oticin, Cortef, Cortenema, Cortifoam, Cortisporin, Efmody, Epifoam, Hydrocortisone, Hydrocortisone / Neomycin / Polymyxin B, Hydrocortone, Micort-hc, Neo-cort-dome, Neo-cortef, Ophthocort, Oticair, Plenadren, Pramosone, Proctofoam, Pyocidin, Solu-cortef, Stie-cort, Terra-cortril, Texacort, Vosol, Xerese (hydrocortisone) is a small molecule pharmaceutical. Hydrocortisone was first approved as Vosol hc on 1982-01-01. It is used to treat adrenal insufficiency, congenital adrenal hyperplasia, contact dermatitis, facial dermatoses, and foot dermatoses amongst others in the USA. It has been approved in Europe to treat adrenal insufficiency and congenital adrenal hyperplasia. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target mineralocorticoid receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Show 1 more
Trade Name
FDA
EMA
Ala-cort, Alkindi, Anusol, Colocort, Cortef, Cortenema, Cortifoam, Hydrocortisone, Khindivi, Micort-hc, Solu-cortef, Stie-cort, Texacort (discontinued: A-hydrocort, Aeroseb-hc, Ala-cort, Balneol-hc, Carmol, Cetacort, Cort-dome, Cortef, Cortril, Dermacort, Eldecort, Epicort, Flexicort, H-cort, Hemsol-hc, Hydrocortisone, Hydrocortone, Hytone, Micort-hc, Nogenic, Nutracort, Orabase hca, Penecort, Stie-cort, Synacort, Texacort, U-cort, Westcort)
CombinationsBacitracin-neomycin-polymyxin w/ hydrocortisone, Casporyn, Cipro, Ciprofloxacin hydrocortisone, Coly-mycin, Epifoam, Hydrocortisone acetic acid, Neomycin polymyxin b sulfates hydrocortisone, Neomycin polymyxin b sulfates, bacitracin hydrocortisone, Oticair, Pramosone, Proctofoam, Vosol, Xerese (discontinued: Acetasol, Acetic acid w/ hydrocortisone, Achromycin, Bacitracin-neomycin-polymyxin w/ hydrocortisone, Calmurid, Chloromycetin hydrocortisone, Cor-oticin, Cortisporin, Hydrocortisone acetic acid, Hydrocortisone pramoxine, Neo-cort-dome, Neo-cortef, Neomycin polymyxin b sulfates hydrocortisone, Neomycin polymyxin b sulfates, bacitracin hydrocortisone, Ophthocort, Orlex, Otobione, Otobiotic, Otocort, Pediotic, Pramosone, Pyocidin, Terra-cortril)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydrocortisone acetate
Hydrocortisone
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CORTENEMA | ANI Pharmaceuticals | N-016199 RX | 1982-01-01 | 1 products, RLD, RS |
| ALKINDI SPRINKLE | Eton Pharmaceuticals | N-213876 RX | 2020-09-29 | 4 products, RLD, RS |
| KHINDIVI | Eton Pharmaceuticals | N-218980 RX | 2025-05-28 | 1 products, RLD, RS |
| CORTEF | Pharmacia & Upjohn | N-008697 RX | 1982-01-01 | 3 products, RLD |
Show 8 discontinued
Hydrocortisone acetate
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CORTISPORIN | Monarch Pharmaceuticals | N-050218 DISCN | 1985-08-09 | 1 products, RLD |
Hide discontinued
Hydrocortisone
+
Neomycin sulfate
Hydrocortisone valerate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| WESTCORT | Sun Pharmaceutical Industries | N-017950 DISCN | 1982-01-01 | 1 products, RLD |
| WESTCORT | Sun Pharmaceutical Industries | N-018726 DISCN | 1983-08-08 | 1 products, RLD |
Hide discontinued
Acyclovir
+
Hydrocortisone
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| XERESE | Bausch Health Companies | N-022436 RX | 2009-07-31 | 1 products, RLD, RS |
Chloramphenicol
+
Hydrocortisone acetate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CHLOROMYCETIN HYDROCORTISONE | Parkedale Pharmaceuticals | N-050202 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydrocortisone sodium phosphate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| HYDROCORTONE | Merck & Co | N-012052 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Hydrocortisone sodium succinate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SOLU-CORTEF | Pharmacia & Upjohn | N-009866 RX | 1982-01-01 | 4 products, RLD, RS |
Hydrocortisone
+
Tetracycline hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ACHROMYCIN | Lederle Laboratories | N-050272 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Bacitracin zinc
+
Hydrocortisone
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CORTISPORIN | Casper Pharma | N-050416 DISCN | 1982-01-01 | 1 products, RLD |
| CORTISPORIN | Monarch Pharmaceuticals | N-050168 DISCN | 1984-05-04 | 1 products, RLD |
Hide discontinued
Chloramphenicol
+
Hydrocortisone acetate
+
Polymyxin b sulfate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| OPHTHOCORT | Parkedale Pharmaceuticals | N-050201 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydrocortisone
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CASPORYN HC | Casper Pharma | N-060613 RX | 1982-01-01 | 1 products, RLD, RS |
Show 2 discontinued
Acetic acid
+
glacial
+
Hydrocortisone
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| VOSOL HC | Saptalis Pharmaceuticals | N-012770 RX | 1982-01-01 | 1 products, RLD, RS |
Ciprofloxacin hydrochloride
+
Hydrocortisone
Colistin sulfate
+
Hydrocortisone acetate
+
Neomycin sulfate
+
Thonzonium bromide
Acetic acid
+
glacial
+
Hydrocortisone
+
Neomycin sulfate
Hydrocortisone cypionate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CORTEF | Pharmacia & Upjohn | N-009900 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| OTC monograph not final | 2012-08-24 | |
| 1% hydrocortisone anti-itch | C200263 | 2026-07-27 |
| 141016 hydrocortisone 0.5% / hydroquinone 4% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
| 141017 hydrocortisone 0.5% / hydroquinone 6% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
| 141060 hydrocortisone 0.5% / hydroquinone 4% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
| 141061 hydrocortisone 0.5% / hydroquinone 8% / tretinoin 0.025% | unapproved drug other | 2020-07-02 |
| 999 itch relieving | OTC monograph not final | 2016-11-14 |
| absolut skin corticosoothe anti-itch | C200263 | 2025-11-19 |
| advanced anti-itch therapy | OTC monograph not final | 2016-06-14 |
| aerosoothe | C200263 | 2026-07-24 |
Show 456 more
Indications
FDA
EMA
Show 74 more
Agency Specific
FDA
EMA
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A01: Stomatological preparations
— A01A: Stomatological preparations
— A01AC: Corticosteroids for local oral treatment
— A01AC03: Hydrocortisone
— A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
— A07E: Intestinal antiinflammatory agents
— A07EA: Corticosteroids acting locally
— A07EA02: Hydrocortisone
C: Cardiovascular system drugs
— C05: Vasoprotectives
— C05A: Agents for treatment of hemorrhoids and anal fissures for topical use
— C05AA: Corticosteroids, topical for treatment of hemorrhoids and anal fissures
— C05AA01: Hydrocortisone
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AA: Corticosteroids, weak (group i)
— D07AA02: Hydrocortisone
— D07AB: Corticosteroids, moderately potent (group ii)
— D07AB02: Hydrocortisone butyrate
— D07AB11: Hydrocortisone buteprate
— D07AC: Corticosteroids, potent (group iii)
— D07AC16: Hydrocortisone aceponate
— D07B: Corticosteroids, combinations with antiseptics
— D07BA: Corticosteroids, weak, combinations with antiseptics
— D07BA04: Hydrocortisone and antiseptics
— D07BB: Corticosteroids, moderately potent, combinations with antiseptics
— D07BB04: Hydrocortisone butyrate and antiseptics
— D07C: Corticosteroids, combinations with antibiotics
— D07CA: Corticosteroids, weak, combinations with antibiotics
— D07CA01: Hydrocortisone and antibiotics
— D07X: Corticosteroids, other combinations
— D07XA: Corticosteroids, weak, other combinations
— D07XA01: Hydrocortisone
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H02: Corticosteroids for systemic use
— H02A: Corticosteroids for systemic use, plain
— H02AB: Glucocorticoids, systemic
— H02AB09: Hydrocortisone
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AD: Corticosteroid nasal preparations for topical use
— R01AD60: Hydrocortisone, combinations
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA02: Hydrocortisone
— S01BB: Corticosteroids and mydriatics in combination
— S01BB01: Hydrocortisone and mydriatics
— S01C: Antiinflammatory agents and antiinfectives in combination
— S01CA: Corticosteroids and antiinfectives in combination, opthalmologic
— S01CA03: Hydrocortisone and antiinfectives
— S01CB: Corticosteroids/antiinfectives/mydriatics in combination
— S01CB03: Hydrocortisone
— S02: Otologicals
— S02B: Corticosteroid otologicals
— S02BA: Corticosteroids
— S02BA01: Hydrocortisone
— S02C: Corticosteroids and antiinfectives in combination, otologic
— S02CA: Corticosteroids and antiinfectives in combination
— S02CA03: Hydrocortisone and antiinfectives
— S03: Ophthalmological and otological preparations
— S03C: Corticosteroids and antiinfectives in combination, opthalmologic and otologic
— S03CA: Corticosteroids and antiinfectives in combination
— S03CA04: Hydrocortisone and antiinfectives
Clinical
Clinical Trials
4119 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 45 | 110 | 43 | 5 | 15 | 189 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 42 | 90 | 37 | 12 | 9 | 163 |
| Leukemia | D007938 | — | C95 | 34 | 93 | 28 | 9 | 12 | 152 |
| Prostatic neoplasms | D011471 | — | C61 | 18 | 68 | 38 | 5 | 15 | 132 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 26 | 62 | 16 | 1 | 2 | 89 |
| Adrenal insufficiency | D000309 | — | — | 7 | 6 | 11 | 24 | 40 | 86 |
| Inflammation | D007249 | MP_0001845 | — | 6 | 10 | 17 | 18 | 32 | 79 |
| Syndrome | D013577 | — | — | 9 | 33 | 11 | 10 | 22 | 77 |
| Healthy volunteers/patients | — | — | — | 28 | 7 | 3 | 10 | 29 | 75 |
| Covid-19 | D000086382 | — | U07.1 | 3 | 9 | 29 | 7 | 30 | 74 |
Show 491 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 23 | 54 | 15 | — | 6 | 84 |
| Graft vs host disease | D006086 | — | D89.81 | 18 | 39 | 16 | — | 7 | 71 |
| Myelodysplastic syndromes | D009190 | — | D46 | 17 | 46 | 5 | — | 4 | 64 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 25 | 27 | 5 | — | 1 | 49 |
| Plasma cell neoplasms | D054219 | — | — | 9 | 17 | 6 | — | 6 | 38 |
| Preleukemia | D011289 | — | — | 5 | 23 | 3 | — | 3 | 29 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 5 | 20 | 4 | — | 1 | 28 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 5 | 18 | 1 | — | 2 | 24 |
| Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 10 | 15 | 5 | — | 1 | 23 |
| Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | 1 | 6 | 9 | — | 7 | 22 |
Show 284 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Motor activity | D009043 | EFO_0003940 | — | — | 2 | — | — | 28 | 30 |
| Stress fractures | D015775 | — | M84.3 | 1 | 1 | — | — | 15 | 17 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 4 | 13 | — | — | 1 | 16 |
| T-cell lymphoma | D016399 | — | — | 8 | 12 | — | — | — | 16 |
| T-cell lymphoma peripheral | D016411 | — | — | 7 | 10 | — | — | — | 13 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 2 | 5 | — | — | 6 | 12 |
| Adrenal gland neoplasms | D000310 | EFO_0003850 | C74 | — | 1 | — | — | 11 | 12 |
| Myeloid leukemia chronic-phase | D015466 | — | — | 2 | 9 | — | — | 1 | 11 |
| Blast crisis | D001752 | — | — | 2 | 8 | — | — | 1 | 10 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 8 | — | — | 1 | 10 |
Show 254 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Overweight | D050177 | — | E66.3 | 1 | — | — | — | 10 | 11 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | 10 | 11 |
| Blood pressure | D001794 | EFO_0004325 | — | 2 | — | — | — | 5 | 7 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | — | — | — | 6 | 7 |
| Alcohol drinking | D000428 | EFO_0004329 | — | 1 | — | — | — | 6 | 7 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | 1 | — | — | — | 5 | 6 |
| Pathologic dilatation | D004108 | — | — | 1 | — | — | — | 4 | 5 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | 1 | — | — | — | 4 | 5 |
| Sleep deprivation | D012892 | — | F51.12 | 2 | — | — | — | 2 | 4 |
| Respiratory aspiration | D053120 | EFO_1001839 | — | 1 | — | — | — | 3 | 4 |
Show 79 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dental implants | D015921 | — | — | — | — | — | — | 12 | 12 |
| Dental anxiety | D016854 | — | — | — | — | — | — | 10 | 10 |
| Psychological burnout | D000077062 | — | Z73.0 | — | — | — | — | 9 | 9 |
| Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 9 | 9 |
| Breast feeding | D001942 | — | — | — | — | — | — | 8 | 8 |
| Psychological distress | D000079225 | — | — | — | — | — | — | 8 | 8 |
| Nursing care | D009732 | — | — | — | — | — | — | 7 | 7 |
| Occupational stress | D000073397 | — | — | — | — | — | — | 7 | 7 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 7 | 7 |
| Wound healing | D014945 | GO_0042060 | — | — | — | — | — | 6 | 6 |
Show 490 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Hydrocortisone |
| INN | hydrocortisone |
| Description | Cortisol is a 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the "stress hormone" as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses. It has a role as an anti-inflammatory drug, an anti-allergic agent, an anti-asthmatic drug, a human metabolite, a mouse metabolite and a drug allergen. It is a 21-hydroxy steroid, an 11beta-hydroxy steroid, a 20-oxo steroid, a 3-oxo-Delta(4) steroid, a primary alpha-hydroxy ketone, a tertiary alpha-hydroxy ketone, a 17alpha-hydroxy-C21-steroid and a glucocorticoid. It derives from a hydride of a pregnane. |
| Classification | Small molecule |
| Drug class | cortisone derivatives |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO |
Identifiers
| PDB | — |
| CAS-ID | 50-23-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL389621 |
| ChEBI ID | 17650 |
| PubChem CID | 5754 |
| DrugBank | DB00741 |
| UNII ID | WI4X0X7BPJ (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
NR3C2
NR3C2
Organism
Homo sapiens
Gene name
NR3C2
Gene synonyms
MCR, MLR
NCBI Gene ID
Protein name
mineralocorticoid receptor
Protein synonyms
aldosterone receptor, mineralocorticoid receptor 1, mineralocorticoid receptor 2, mineralocorticoid receptor delta, Nuclear receptor subfamily 3 group C member 2
Uniprot ID
Mouse ortholog
Nr3c2 (110784)
mineralocorticoid receptor (Q8VII8)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Diprospan – Organon
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
Hydrocortisone
+
Benzoyl peroxide
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
+
Ciprofloxacin
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
+
Clioquinol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
+
Lidocaine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
+
Neomycin
+
Polymyxin b
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
+
Oxytetracycline
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
+
Polymyxin b
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrocortisone
+
Pramoxine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 131,296 documents
View more details
Safety
Black-box Warning
Black-box warning for: Ciprofloxacin, Ciprofloxacin hcl, Ciprofloxacin in dextrose, Proquin, Proquin xr
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
39,574 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use